These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development. Hurevich M; Talhami A; Shalev DE; Gilon C Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995 [TBL] [Abstract][Full Text] [Related]
6. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype. Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137 [TBL] [Abstract][Full Text] [Related]
7. Characterization of [ Takano A; Nag S; Jia Z; Jahan M; Forsberg A; Arakawa R; Grybäck P; Duvey G; Halldin C; Charvin D Mol Imaging Biol; 2019 Jun; 21(3):500-508. PubMed ID: 30066121 [TBL] [Abstract][Full Text] [Related]
8. SAR studies on mGlu5 receptor positive allosteric modulators (2003- 2013). Hao J; Xiong H Curr Top Med Chem; 2014; 14(15):1789-841. PubMed ID: 25176124 [TBL] [Abstract][Full Text] [Related]
9. Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer. Liu J; Zhang Z; Moreno-Delgado D; Dalton JA; Rovira X; Trapero A; Goudet C; Llebaria A; Giraldo J; Yuan Q; Rondard P; Huang S; Liu J; Pin JP Elife; 2017 Aug; 6():. PubMed ID: 28829739 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of N-(methylthiophenyl)picolinamide derivatives as PET radioligands for metabotropic glutamate receptor subtype 4. Kil KE; Poutiainen P; Zhang Z; Zhu A; Kuruppu D; Prabhakar S; Choi JK; Tannous BA; Brownell AL Bioorg Med Chem Lett; 2016 Jan; 26(1):133-9. PubMed ID: 26602273 [TBL] [Abstract][Full Text] [Related]
11. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor. Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of bivalent tethered ligands to target the mGlu Fulton MG; Loch MT; Rodriguez AL; Lin X; Javitch JA; Conn PJ; Niswender CM; Lindsley CW Bioorg Med Chem Lett; 2020 Jul; 30(13):127212. PubMed ID: 32371100 [TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research. Litim N; Morissette M; Di Paolo T Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772 [TBL] [Abstract][Full Text] [Related]
20. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2. Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]